Subtle Cognitive Impairments and Psychological Complaints in Patients With Prolactinoma Despite Biochemical Control
Open Access
- 13 June 2025
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (1) , e9-e22
Abstract
Purpose: To assess cognitive functioning and psychological complaints in patients with biochemically controlled prolactinoma. Methods: Cross-sectional study comparing otherwise healthy patients treated for prolactinoma to age-, gender-, and education level-matched controls. The cognitive assessment included 8 tests assessing memory, verbal fluency, processing speed, selective attention, and executive functioning. Additionally, patients completed 7 validated questionnaires on psychological complaints. Generalized estimating equations were performed. P values <.050 were considered significant. Results: Sixty patients (controlled on dopamine agonists, n = 30; in surgical remission, n = 30), among whom 41 (68.3%) females, aged 42.3 ± 11.7 years, were compared to 60 matched controls. Patients scored significantly lower on assessments for verbal memory (fewer words on Verbal Learning Test of Rey: β = −1.8; 95% CI, −2.7 to −1.0), selective attention (fewer correct digits on Digit Deletion Test [β = −8.8; 95% CI, −16.2 to −0.2], longer time on Trial Making Test A [β = 5.2; 95% CI, 3.2 to 7.2]), and processing speed (fewer correct substitutions on Digit-Symbol Substitution Test: β = –4.2; 95% CI, −8.2 to −0.2). Furthermore, patients reported higher degrees of apathy (Apathy Scale: β = 2.4; 95% CI, 0.6 to 4.1), irritability (Irritability Scale: β = 2.2; 95% CI, 0.3 to 4.1), fatigue (Fatigue Severity Scale: β = 6.7; 95% CI, 2.7 to 10.8), and anxiety and depressive symptoms (Hospital Anxiety and Depression Scale, anxiety: β = 1.1; 95% CI, 0.1 to 2.1; depression: β = 1.7; 95% CI, 0.8 to 2.7). Tests assessing executive functioning and task switching were comparable in patients and matched controls. Conclusion: Compared to matched controls, patients with biochemically controlled prolactinoma showed subtle cognitive impairments (ie, memory, attention, and processing speed) and reported more psychological complaints. Physicians should be aware of these impairments and address them adequately.Keywords
This publication has 39 references indexed in Scilit:
- Quality of life in Prolactinoma: A systematic reviewPituitary, 2024
- Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?Pituitary, 2023
- Endoscopic Surgery for Pituitary TumorsEndocrinology and Metabolism Clinics of North America, 2020
- Theta oscillations in prolactinomas: Neurocognitive deficits in executive controlsNeuroImage: Clinical, 2020
- Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory ImpairmentJAMA, 2017
- The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-PituitaryPituitary, 2016
- Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoLPituitary, 2014
- Executive functions recover earlier than episodic memory after microsurgical transsphenoidal resection of pituitary tumors in adult patients – a longitudinal studyJournal of Clinical Neuroscience, 2011
- Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive ControlBiological Psychiatry, 2011
- Multiplicity in randomised trials I: endpoints and treatmentsThe Lancet, 2005